Skip to content

Perspectives on Diabetes Care

This is the official blog of the Association of Diabetes Care & Education Specialists where we share recent research and professional opinions on diabetes care and education.


Explore Helpful Views on Diabetes Care & Education

If you're looking for professional opinions on diabetes care and education, you're in the right place. Perspectives on Diabetes Care is the official ADCES® diabetes care and education blog that shares helpful views on diabetes care and education. 

This is where you'll find practical tips on working with people affected by prediabetes, diabetes and related cardiometabolic conditions and the latest research and viewpoints on issues facing diabetes care and education specialists and the people they serve.



Current & Past ADCES Blog Articles


Turn a negative into a positive

Nov 25, 2014, 06:00 AM

How many times have you heard one of the following statements in general conversation or at clinical practice?  “I am a diabetic,” “The person is a diabetic,”  “The person is hypertensive and a diabetic,” “The patient is hyperglycemic,” or “The patient is hypoglycemic.”

This type of phrasing was written about last year in an AADE blog.  I wanted to bring it up for discussion again among the membership.  I have been in clinic many times over the past several months, and heard adjectives used to describe patients.  I even attended a national pharmacy meeting and listened to a presenter’s lecture on patient-centered medical home.  Throughout this presentation, I heard the same thing – adjectives used to describe patients.  It is very discouraging to describe patients or any individual as an adjective.  Let’s make this negative a positive for our patients. People are not adjectives; they are nouns – a human being to be exact.  Therefore, we should be correct when addressing people as individuals WITH a disease state.

On another note, there have been several medications approved for diabetes mellitus this year.  Here is a summary of the medications:

• Dapagliflozin (or Farxiga) – SGLT-2 inhibitor
• Empagliflozin (or Jardiance) – SGLT-2 inhibitor
• Albigutide (or Tanzeum) – GLP-1 agonist
• Dulaglutide (or Trulicity) – GLP-1 agonist
• Inhaled insulin (or Afrezza) – rapid-acting insulin

There is no “perfect” medication on the market for any disease state. While a medication may be efficacious, there can be risks associated with the medication.  Patients may or may not experience adverse events with a specific medication. We could agree and disagree on the “me-too drugs” that have been approved or the difficulty in selecting a specific agent within a therapeutic class. However, let’s make this negative thought into a positive one. We should be thankful for the variety of options for diabetes mellitus. These options allow us to truly individualize the plan for a patient based on numerous factors.

For any issue that is discussed in clinical practice with providers, colleagues, or patients, always think on the brighter side and be positive!

Association of Diabetes Care & Education Specialists

Contact Us